Biovalley expects an attributable net profit loss of 10.2 million yuan to 13.13 million yuan for the

Mondo Finance Updated on 2024-02-29

**Star News, Biovalley released a performance forecast, and it is expected that the attributable net profit loss for the whole year of 2023 will be 10.2 million yuan to 13.13 million yuan.

The announcement explained the reasons for the change in performance:

During the reporting period, the net profit attributable to shareholders of listed companies and the net profit loss attributable to shareholders of listed companies after deducting non-recurring gains and losses decreased year-on-year, and the basic earnings per share were -009 yuan, the main reasons are as follows: In the same year, while stabilizing the existing market, the company increased the development of blank markets and terminals according to the actual situation in various regions, actively and effectively carried out professional brand publicity activities, and promoted the company's sales revenue to increase. 2. During the reporting period, other income was 1,253$0.65 million, a decrease of 2,359 from the same period last year790,000 yuan, mainly due to the decrease in the ** subsidy for deferred amortization in the current period. 3. During the reporting period, the shareholders Shenzhen GSR Investment*** hereinafter referred to as "GSR") and Mr. Lin Yanhe failed to return the funds of the listed company in full according to the commitment period, and the company combined with the progress of repayment, in accordance with the principle of prudence, the remaining outstanding debts were provided for impairment by means of individual assessment of credit risk, and the amount of bad debts accrued in the current period was 43.69 million yuan, the amount of bad debts accrued in the previous period was 89.95 million yuan, and the cumulative amount of bad debts was 133.64 million yuan. The company will further maintain communication with shareholders Jinshajiang and Mr. Lin Yanhe to work on the solution of capital occupation.

Biovalley's third quarter report for 2023 shows that the company's main revenue is 46.9 billion yuan, an increase of 10 percent year-on-year45%;Net profit attributable to the parent company was 604410,000 yuan, a year-on-year decrease of 5752%;Non-net profit deducted - 402660,000 yuan, an increase of 59 year-on-year14%;Among them, in the third quarter of 2023, the company's single-quarter main revenue is 15.6 billion yuan, an increase of 972%;The net profit attributable to the parent company in a single quarter was 100310,000 yuan, an increase of 19 year-on-year3%;The non-net profit deducted in a single quarter was 805880,000 yuan, an increase of 1929 year-on-year99%;The debt ratio is 1927%, investment income 41990,000 yuan, financial expenses 12280,000 yuan, gross profit margin of 8099%。

The above content is compiled by **Star based on public information, generated by algorithms, and has nothing to do with the position of this site. **Star strives but does not guarantee the accuracy, completeness, validity, timeliness of all or part of the content of the information (including but not limited to text, **audio, data and charts), if there is any problem, please contact us. This article is a compilation of data and does not constitute any investment advice for you.

Related Pages